Johnson & Johnson has applied for a COVID-19 Emergency Use Authorization (EUA) from the FDA, the company announced on Thursday, February 4. The application pertains to J&J’s Janssen COVID-19 vaccine candidate, a single-shot product that is ready to be shipped to distributors ‘immediately following authorization,’ Johnson & Johnson said. On January 29, Johnson & Johnson announced that its single-shot COVID-19 … Continue reading
The text above is a summary, you can read full article here.